Longtime professor of medicine Dr. Sanjiv M. Narayan has held teaching roles at colleges throughout California, including UC San Diego. He is currently a faculty member at Stanford University and the director of the Stanford Arrhythmia Center. A committed cardiologist and researcher, Sanjiv Narayan, MD, PhD, is a leading authority in the diagnosis and treatment of atrial fibrillation.In January 2018, the United States Food and Drug Administration gave approval for the use of a new type of ablation catheter for the treatment of atrial fibrillation. Developed by Abbott, the TactiCath Contact Force Ablation Catheter SE (Sensor Enabled) discourages the electrical stimulations that can scar heart tissue. Physicians who have tried the catheter have praised it as a major advance in ablation therapy. Srijoy Mahapatra, MD, of Abbott says the TactiCath SE is the latest innovation in the company’s mission to advance ablation therapy by making it safer and easier to perform.
Sanjiv M. Narayan, MD, PhD, is a cardiologist serving Stanford University as a professor of medicine who focuses on innovative bioengineering solutions for treating arrhythmias and other cardiovascular conditions. A former professor of medicine at UC San Diego, Sanjiv Narayan additionally supports professional organizations such as the Heart Rhythm Society (HRS), which encourages the highest possible standards in the delivery of healthcare as part of its mission of education and the promotion of research and heart-healthy public policy. The society, based in Washington D.C., serves the professional cardiology community and the general public as a major destination for information on electrophysiology and cardiac pacing. Its membership includes professionals from dozens of nations who focus on studying and treating heart arrhythmias. As part of its educational efforts, HRS offers a range of continuing medical education courses for professionals in the field, with registration information detailed at its website’s Learning Center. Among these courses is one on atrial fibrillation ablation, providing a full review of the topic, as well as information on emerging procedures. Another course discusses mapping in the treatment of AF, and still another provides updates on the use of medical devices to treat heart conditions.HRS also provides select access to online discussion portals, such as one offering hundreds of hours of presentations taken from the organization’s latest annual Scientific Sessions conference, held in May 2018 in Boston. San Francisco will be the site of the 2019 Scientific Sessions in May, with full details provided on the HRS website.
